PetIQ Inc
Sector:
Health Care
Website: www.petiq.com
Industry:
Health Care Providers & Services
Number of Employees:
1 452
Sub-Industry:
Health Care Distributors
Primary Exchange:
NASDAQ GS
Accounting Standard:
US GAAP
Stock Quote & Chart (Currency: USD)
Last price (delayed quote):
31.1
Market Cap (M)
879
52 Wk High
36.1
Shares Out. (M)
28.2723
52 Wk low
22.24
Float
83%
Price Performance Dividend Yield
-
1M Return
1.3%
Diluted EPS Excl. XO
0.4
6M Return
(0.7%)
P / Diluted EPS Before XO
81.0
52 Wk Return
5.10%
Beta (unlever.)
1.26
YTD Return
24.15%
Avg. Vol - 3 mo (M)
0
Equity Value (Currency: USD , in mln)
Market Capitalization
879
Book Value of Common Equity
286
- Cash & Short Term Investments
10
+ Total Debt
282
+ Total Debt
282
+ Pref. Equity
-
+ Pref. Equity
-
+ Total Minority Interest
49
+ Total Minority Interes
49
= Enterprise Value
1 200
= Total Capital
569
Credit Ratings Rating Outlook
S&P
-
Moody's
-
Fitch
-
Financial Information (Currency: USD, in mln)
(12M Trail)
Revenue
666
Cash from Operations
(6)
Gross Profit
103
Cash From Investing
(192)
EBITDA
24
Cash from Financing
204
EBIT
4
Net Change in Cash
5
Net Income
(3)
CAPEX
(6)
Free Cash Flow
(12)
Valuation Multiples
Actual
31-12-2018
12M trailing
30-09-2019
EV/Revenue 2.3x 1.8x
EV/EBITDA 59.4x 50.0x
EV/EBIT 154.9x 300.1x
P/E 10106.5x -175.9x
P/BV 2.7x 3.1x
Description
PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.
Revenue Breakdown (2018)